4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
FIND DIAGNOSIS
FIND DIAGNOSIS
Find Diagnosis
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
POST-EXPOSURE PROPHYLAXIS (PEP)
Post Exposure Prophylaxis(PEP)
PEP Risk Reduction
How to Reduce This Risk?
Dr Tripti Pensi
Professor of Pediatrics, Dr.R.M.L Hospital, New Delhi

How to reduce this risk?

Continued...

How does PEP works?


PEP is recommended because it has been observed that systemic infection does not occur immediately after an exposure and there is a brief window period of opportunity available to contain or eradicate HIV from body before wide spread cellular infection occur. After a needle-stick injury, immune cells (dendritic) in skin present the HIV to T-lymphocytes and natural killer cells. It is seen that in monkey models, Simian immunodeficiency virus (SIV) when injected into vagina, virus is engulfed by immune cells in the vaginal lining. Within 2 days SIV is found in inguinal lymph nodes. Within 5 days SIV infected T-cells and free SIV can be detected in blood stream 9. Migration of SIV after rectal or penile tip exposure follows a similar time frame. PEP can stop viral replication during this early period before it gains a 'foothold' in the body.

Is post-exposure prophylaxis recommended for all types of occupational exposures to HIV?



No, because most occupational exposures do not lead to HIV infection. The chances of possible serious side effects (toxicity) from the drugs used for PEP may be much greater than the chance of HIV infection from such exposures. Both risk of infection and possible side effects of drugs should be carefully considered when deciding whether to give post-exposure prophylaxis or not.

The decision to start PEP is made on the basis of degree of exposure to HIV (Exposure Code) and the HIV status of the source (HIV Status Code) from whom the exposure has occurred. The Exposure Code and Status Code are then correlated to arrive at a decision regarding initiation of PEP.

Determination of the Exposure Code (EC):
Exposure code can be defined as per the flow chart given below. It may be classified into three categories, EC-1, EC-2 and EC-3, depending upon the severity of exposure.

Determination of Exposure Code
Determination of Exposure Code

Determine the PEP recommendation

EC HIV SC   PEP recommendation
1 1   PEP may not be warranted
1 2  
Considerbasic regimen.
(Exposure type poses a negligible risk for HIV transmission).
2 1  
Recommend basic regimen
(Most HIV exposures are in this category; no increased risk for HIV transmission has been observed but use of PEP is appropriate).
2 2  
Recommend expanded regimen.
(Exposure type represents an increased HIV transmission risk.)
3 1 or 2  
Recommend expanded regimen.
(Exposure type represents an increased HIV transmission risk.)
  UNKNOWN
If the source, (in the case of an unknown source), the setting where the exposure occurred suggests a possible risk for HIV exposure and the EC is 2 or 3, consider PEP basic regimen.

What specific drugs are recommended for PEP?


Basic Regimen:

(4 weeks therapy)
- Zidovudine (AZT/ZDV) - 300mg twice a day is used for all types of exposure
+
Lamivudine (3TC) - 150 mg twice a day is added to increase the effectiveness of ZDV and to prevent resistance to ZDV
Expanded Regimen:

(4 weeks therapy)
- Basic Regimen (AZT/ZDV+3TC)
+

Indinavir - 800 mg/thrice a day or any other protease inhibitor is added for highest risk categories.

These are the guidelines recommended at present by National AIDS Control Organization, Government of India. However, with the use of anti retroviral therapy for HIV infected patients, the issue of transmission of drug resistant virus (particularly in developed world where large number of infected persons are on triple therapy) is emerging as a serious consideration in choosing drugs for PEP. Detailed guidelines in this regard can be accessed from updated USPHS guidelines issued in June 2001.

However, due to relatively lesser number of HIV infected individuals on triple therapy and an overall low prevalence of HIV in our country, presently above guidelines are being followed. The Physicians dealing with HIV medicines may modify these guidelines depending on the source, risk and their experience.




 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us